Avicanna Inc (TSE:AVCN) has released an update.
Avicanna Inc. has reported a significant 314% increase in annual revenue for 2023, hitting $16.8 million, with a 500% surge in gross profits to $6.7 million, marking a year of substantial financial growth. These impressive results, following the acquisition of Medical Cannabis by Shoppers and the launch of MyMedi.ca, have bolstered the company’s leadership in the Canadian medical cannabis sector. Avicanna’s CEO highlights the scalability of revenue and advancements in their R&D and pharmaceutical initiatives.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.
